JPS59163382A - Novel beta-hydroxy ester and its preparation - Google Patents

Novel beta-hydroxy ester and its preparation

Info

Publication number
JPS59163382A
JPS59163382A JP3808483A JP3808483A JPS59163382A JP S59163382 A JPS59163382 A JP S59163382A JP 3808483 A JP3808483 A JP 3808483A JP 3808483 A JP3808483 A JP 3808483A JP S59163382 A JPS59163382 A JP S59163382A
Authority
JP
Japan
Prior art keywords
genus
formula
beta
hydroxy ester
ether
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP3808483A
Other languages
Japanese (ja)
Inventor
Takeshi Oishi
大石 武
Koki Horikoshi
弘毅 掘越
Hiroyuki Akita
秋田 弘幸
Hiroko Koshiji
越地 弘子
Akinari Furuichi
古市 昭也
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RIKEN Institute of Physical and Chemical Research
Original Assignee
RIKEN Institute of Physical and Chemical Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RIKEN Institute of Physical and Chemical Research filed Critical RIKEN Institute of Physical and Chemical Research
Priority to JP3808483A priority Critical patent/JPS59163382A/en
Publication of JPS59163382A publication Critical patent/JPS59163382A/en
Pending legal-status Critical Current

Links

Abstract

NEW MATERIAL:A compound shown by the formula I (X is alpha-CH2, or beta-CH3; Y is alpha-OH, or beta-OH). USE:An intermediate raw material for synthesizing an antibacterial agent. For example, useful as an intermediate raw material for synthesizing erythromycin showing high antibacterial activity against Gram-positive bacteria, useful for microbism, oudemansin showing an inhibitory action of nucleic acid synthesis on Ehrlich ascites carcinoma cell, indolmycin, or applidiasphingosine. PREPARATION:A beta-keto ester shown by the formula II (R1 is 2-tehienyl; R2 is alkyl) is brought into contact with a microorganism belonging to the genus Candida, Endomycopsis, Hansenula, Kloeckera, Lipomyces, Saccaromyces, Schizosaccharamyces, or Sphorobolomyces or its mold, to give the desired compound shown by the formula I .

Description

【発明の詳細な説明】 エ (ただし、式中、×はα−CH3  またはβ−C)−
13、Yはα一〇Hまたはβ−OHを示す。ンで表わさ
れる新規なβ−ヒドロキシエステル並びに、一般式:(
ただし、式中、R工はコーチェニル基を示し、R2 は
、アルキル基を示す。) で表わされる化合物を、カンテイ〆( Candlda
 )属をはじめとする各種酵母菌と接触させて、一般式
: (ただし、式中、Rユ、R2は前記に同じ。)で表わさ
れる化合物を得ることを特徴とするヒドロキシエステル
の新規な製造法に関するものである。
[Detailed description of the invention] E (wherein, × is α-CH3 or β-C)-
13, Y represents α10H or β-OH. A novel β-hydroxy ester represented by the formula: (
However, in the formula, R represents a coachenyl group, and R2 represents an alkyl group. ) Candlda
) Novel production of hydroxy ester, characterized in that a compound represented by the general formula: (wherein R, R2 are the same as above) is obtained by contacting with various yeasts, including those of the genus It is about law.

ここで、上記β−ヒドロキシエステルとしては、次の’
l 1M類の光学異性体を挙げることができる。
Here, as the above β-hydroxy ester, the following '
l 1M optical isomers can be mentioned.

(A)         (C) δ)(            OH (8)         (DJ (A)及び(B)をS y n体、(C)及び(D)を
A。11体と称する。
(A) (C) δ)(OH (8) (DJ) (A) and (B) are called Syn bodies, and (C) and (D) are called A.11 bodies.

本発明の目的物質は、例えば次に示すような各種有用な
物質へ変換する際の重要な原料化合物となりつる。
The target substance of the present invention can serve as an important raw material compound when converted into various useful substances, such as those shown below.

例えば、ダラム陽性菌に対して強い抗菌活性を示し、毒
性が低いので広く細菌感染症に使用されているエリスロ
マイシン( Erythromycln )  を合成
する際の重要な中間原料として有用である。
For example, it exhibits strong antibacterial activity against Durham-positive bacteria and has low toxicity, making it useful as an important intermediate raw material in the synthesis of erythromycin, which is widely used for bacterial infections.

また、強い抗菌活性を示し,且つエーリツヒ腹水型鹿瘍
細胞に対して核酸合成阻害作用を示す抗生物質オーデマ
ンシン( Ouclemansln )  を合成する
際の重要な中間原料としても有用である( TlmAn
ke et al.The Journal of A
ntlblotlcs.p///2。
It is also useful as an important intermediate raw material when synthesizing the antibiotic Oudemansin, which exhibits strong antibacterial activity and inhibits nucleic acid synthesis against Ehrlitsu ascites-type deer ulcer cells (TlmAn).
Ke et al. The Journal of A
ntlblotlcs. p///2.

Nov./ 9 7 q参照)。Nov. / 9 7 q).

OC83COOCI−13 さらに、ストレプトミセス・アルパス ( Streptomyces albus)より単離
され各種市販の抗生物質に対して耐性を有するある種の
ブドウ球菌に対して抗菌性を有するインドールマイシン
( lndolmycln )  を合成する際の中間
原料とじても有用である( W、 S、 Marsh 
et at Antlblot。
OC83COOCI-13 Furthermore, in the synthesis of indolmycln, which is isolated from Streptomyces albus and has antibacterial properties against certain types of staphylococci that are resistant to various commercially available antibiotics. It is also useful as an intermediate raw material (W, S, Marsh
et at Antlblot.

Chemother、 、 10 、3 / b (/
 9乙0)参照)。
Chemother, , 10, 3/b (/
(See 9 Otsu 0)).

III    −2c、              
   [インドールマイシン〕Mθ H さらにまた、海洋生物のホヤの一種であるアブリジウム
(At)l ldlum sp、)より単離され抗菌性
及びにB及びL/210腫瘍細胞に対して抗腫瘍性を示
すアプリシアスフィンゴシン(Apl 1dlasph
l −ngoslne )の中間原料としても有用であ
る。
III-2c,
[Indolmycin] Mθ H Furthermore, it is isolated from Abridium (At) ldlum sp., a type of sea squirt, and exhibits antibacterial and antitumor properties against B and L/210 tumor cells. Cyasphingosine (Apl 1dlasph
It is also useful as an intermediate raw material for l-ngoslne).

これらの有用な天然物を合成するためには、天然物と同
じ絶対配位す有する光学活性な化合物を得ることが必要
となる。
In order to synthesize these useful natural products, it is necessary to obtain optically active compounds having the same absolute coordination as the natural products.

これらの化合物を合成する方法としては、ム、Mg+1
のようなキレートコ価陽イオン又HLDA(リチウムジ
イソプロピルアミド)の存在下で相当するエルレートと
相当するアルデヒドをアルドール縮合させて、相当する
アルドールを得る方法あるいは、還元剤としてNa8H
4、L I BH4な用いる方法等が知られている。し
かしながら、前者は反応条件の設定が厳しく、又原料の
エルレートも立体化学的に規制されたものを用いなけれ
ばならない。一方、後者は、その選択率が充分といえず
、分子内にエステル基が存在すると、ゆきすぎ還元が生
じる等の欠点を有する。
As a method for synthesizing these compounds, Mg, Mg+1
A method of aldol condensation of the corresponding erulate and the corresponding aldehyde in the presence of a chelate covalent cation such as HLDA (lithium diisopropylamide) to obtain the corresponding aldol, or using Na8H as a reducing agent.
4. Methods using L I BH4 are known. However, in the former method, the reaction conditions must be set strictly, and the raw material erlate must also be stereochemically regulated. On the other hand, the latter has drawbacks such as insufficient selectivity and the presence of an ester group in the molecule, resulting in excessive reduction.

又、上記の方法では、いずれにしても光学活性なβ−ヒ
ドロキシエステル類は得られず、相当するラセミ体しか
得られていない。
Moreover, in any case, optically active β-hydroxy esters cannot be obtained by the above-mentioned methods, but only the corresponding racemates are obtained.

そこで、本発明者らは、温和な反応条件下で、しかも原
料化合物の立体化学に規制されずに前記光学活性なβ−
ヒドロキシエステルを得る方法について鋭意研究を行っ
た結果、化学的還元法ではlく、カンデイダ属を初めと
する釉々の阿世に属  jする微生物を用いて、高収率
にて、且つ高い光学純度を有する光学活性β−ヒドロキ
シエステルを得ることな見出し、本発明を完成するに至
った。
Therefore, the present inventors developed the optically active β-
As a result of intensive research into methods for obtaining hydroxyesters, we found that chemical reduction methods were not possible, and we were able to obtain hydroxyesters in high yield and with high optical purity using microorganisms belonging to the glaze genus, including the genus Candida. The present invention was completed based on the discovery that it is possible to obtain an optically active β-hydroxy ester having the following properties.

以下に本発明を詳述する。The present invention will be explained in detail below.

まず本発明の出発物質であるβ−ケトニスチル(IV)
は、例えば次のような工程によって得ることができる。
First, β-ketonistyl (IV), which is the starting material of the present invention,
can be obtained, for example, by the following steps.

(IV) (式中、Xはハロゲン、R1,R2は前記に同じ。)す
なわち、相当するアルデヒド(1)とα−710エステ
ル(n)をムの存在下で縮合反応させるとβ−ヒドロキ
シエステル(I)(この場合は、前記4 a類(7)丸
字異性体(A)、(B)、(C)、(D)の混合物)が
得られる〔リフオルマツキー(Reformatsky
 )反応〕。
(IV) (wherein, (I) (in this case, a mixture of the round-shaped isomers (A), (B), (C), and (D) of Group 4a (7)) is obtained [Reformatsky
)reaction〕.

′与られたβ−ヒドロキシエステル(冨)を酸化剤、例
えば、ジョーンズ試薬、ピリジニウムジクロメイト(P
DC)−CH2α2、Cl−13COOH−ピリジン−
DMSO等で処理すると出発物質QV)が得られる。
'The given β-hydroxy ester (total) is treated with an oxidizing agent, e.g. Jones reagent, pyridinium dichromate (P
DC)-CH2α2, Cl-13COOH-pyridine-
Treatment with DMSO etc. gives the starting material QV).

又、得られたβ−ケトニスチルを、相当するアルコール
と反応させることにより、エステル交換な行ってエステ
ル部分めR2を適宜置き換えることかできる( M、T
an1Huchl et al Chem、Pharm
In addition, by reacting the obtained β-ketonistyl with the corresponding alcohol, transesterification can be performed to appropriately replace the ester moiety R2 (M, T
an1Huchl et al Chem, Pharm
.

Bull9,2θ、/11.3gC/972)参照)。(See Bull9, 2θ, /11.3gC/972).

(IV)            (IV’)又、相当
するエステル(R□C0OR)  とゾロピオン酸エス
テル(CH30H2GOOR2)を、塩基、例えば、L
DA(リチウム−ジインゾロピルアミド)、アルカリ金
属アルコラードの存在下で縮合させても得ることができ
る。
(IV) (IV') Alternatively, the corresponding ester (R
It can also be obtained by condensation in the presence of DA (lithium-diynzolopyramide) and an alkali metal alcoholade.

かくして得られた化合物昨)を出発物質として、これに
、以下に示す微生物又はその菌体な接触せしめて、本発
明の目的化合物である光学活性β−ヒドロキシ−エステ
ルを得ることができる。
The optically active β-hydroxy-ester, which is the target compound of the present invention, can be obtained by using the thus obtained compound (2) as a starting material and contacting it with the following microorganisms or their cells.

、  上記微生物は、カンディダ(Candlda )
属、エンドマイコブシス(Enclomycopsls
)属、ハンセヌラ(Hanser+ula )属、クロ
ッケラ(にIoeckera)属、リポマイセス(Ll
pomyces )属、サツカロマイセス(Sacch
aromyces )属、シゾサツ力ロマイセス(Sc
hlzosaccharomyces )属及びスポロ
)p。
, the above microorganism is Candida
Genus, Enclomycopsls
) genus, Hansenula (Hanser+ula) genus, Crockera (Ioeckera) genus, Lipomyces (Ll
pomyces), Saccharomyces (Sacch)
Sc.
hlzosaccharomyces) and Sporo) p.

マイセス(Sporobolomyces )  属に
属する微生物群から選ばれる微生物であり、例えば、第
1表に示す微生物を代表例として挙げることができる。
The microorganism is selected from the group of microorganisms belonging to the genus Sporobolomyces, and representative examples include the microorganisms shown in Table 1.

第1表中゛、&弘から應7、K/2及び屋コtは、それ
ぞれ、昭和37年2月26日付にて、工業技術院微生物
工業技術研究所で受託された微生物であり、V″FER
MP−“は、それぞれの受託番号を示す。上記微生物は
いずれも以下に示す公知文献に記載されている公知の微
生物である。
In Table 1, ゛, &Hiro to 〇7, K/2, and Yakot are microorganisms commissioned by the Institute of Microbial Technology, Agency of Industrial Science and Technology on February 26, 1960, respectively, and V ″FER
MP-" indicates each accession number. All of the above microorganisms are known microorganisms described in the known documents shown below.

CzechOslovak Co11ectlons 
of Mlcroorganlsmus。
CzechOslovak Co11ectlons
of Mlcroorganlsmus.

Catalogue of Cu1tures、 Br
no、 January /q12’f長尾研究所菌類
研究報告(/ ? 55 ) : The Japan
eseFederatlon of Cu1ture 
Co11ectlon ofMlcroorganls
ms、 JFCCCatalogue of Cult
ures又Ag%A/A、A2乙及び墓36は、それぞ
れ財団法人発酵研究所(IFO)の保存菌株であり、何
人も入手可能である[: lN5TITUTE FOR
FERMENTATION O8AにA、LIST O
F CULTURES/9’7g  4thEDITI
ON:(参考資料/#照)]。
Catalog of Cultures, Br
no, January /q12'f Nagao Research Institute Fungi Research Report (/?55): The Japan
eseFederatlon of Culture
Co11ectlon ofMlcroorganls
ms, JFCC Catalog of Cult
ures, Ag%A/A, A2 Otsu, and Grave 36 are the preserved strains of the Institute for Fermentation Research (IFO), and are available to anyone [: lN5TITUTE FOR
FERMENTATION O8A, LIST O
F CULTURES/9'7g 4thEDITI
ON: (Reference Material/#Shi)].

なお、上記IFOの保存菌株のうち、屋36は、−m−
1米国の保存機関であるジ・アメリカン・タイプ・カル
チャー・コレクションCTHEAMERICAN TY
PE CULTURE C0LLECTION(ATC
C) )の保存菌株である( ATCCCatalog
ueofstrains I、 /3 th Edit
ion、 197g (針考資料ユ)参照)。
In addition, among the above-mentioned IFO preserved strains, Ya36 is -m-
1 The American Type Culture Collection, a U.S. preservation institution
PE CULTURE COLLECTION (ATC
C) ) is a conserved strain of ( ATCC Catalog
ueofstrains I, /3 th Edit
ion, 197g (see needle review material)).

なお、以下微生物は、便宜上、”KSY−!“等と称す
ること圧する。
Hereinafter, for convenience, the microorganisms will be referred to as "KSY-!", etc.

本発明のβ−ヒドロキシエステルを製造するには、まず
上記微生物を適当な培地に接種し、培養を行う。培養は
、酵母の通常の培養方法によって行われるが、例えば、
バレイショ、ショ糖、グルコース、カゼイン分解物等を
含む培地で一定時間振とり又は攪拌培養を行って菌体な
増殖させる。
In order to produce the β-hydroxy ester of the present invention, the above-mentioned microorganism is first inoculated into a suitable medium and cultured. Cultivation is carried out using normal yeast culturing methods, for example,
The cells are grown by shaking or stirring culture for a certain period of time in a medium containing potato, sucrose, glucose, casein decomposition products, etc.

次いで前記、出発物質を添加し、更に培養を行う。Next, the above-mentioned starting material is added and further culturing is performed.

又、菌体な増殖させた後、遠心分離等の操作によ2て菌
体な分離後、新たに該菌体に、上記炭素源、水等と共に
、前記出発物質な加え、更に培養を行ってもよい。培養
温度は、通常2g〜37C程度、好ましくは30C程度
であわ、培養時間は、通常/〜/2θ時間程度、好まし
くは、2〜72時間程度が適当である。
Further, after the bacterial cells have been grown, the bacterial cells are separated by an operation such as centrifugation, and the starting material is newly added to the bacterial cells together with the carbon source, water, etc., and the cells are further cultured. It's okay. The culture temperature is usually about 2g to 37C, preferably about 30C, and the culture time is usually about /2θ hours, preferably about 2 to 72 hours.

得られた培養物な例えば、セライト等を用いて濾過し、
p液を常法通り有機溶剤で抽出、その後乾燥、溶媒留去
すると粗β−ヒドロキシエステル(V)を得る。精製法
は、例えば、次の如くである。
The obtained culture is filtered using, for example, Celite,
The p solution is extracted with an organic solvent in a conventional manner, then dried and the solvent is distilled off to obtain crude β-hydroxy ester (V). The purification method is, for example, as follows.

粗β−ヒドロキシエステル(V)を直接シリカダル力ラ
ムうロマトグラフイーに付すと、相当する光学活性、t
 s、n体〔(A)又は(B)〕及びAntl 体〔(
C)又は(D)〕を分離することができる。しかし上記
の方法で分離・精製が困難な場合は、次のような方法に
よって、相当する光学活性なS y n体〔(A)又は
(B)〕及びAnt1体〔(C)又は(D)〕を分離す
ることができる。
When the crude β-hydroxy ester (V) is directly subjected to silica column chromatography, the corresponding optical activity, t
s, n form [(A) or (B)] and Antl form [(
C) or (D)] can be separated. However, if it is difficult to separate and purify using the above method, the corresponding optically active Syn form [(A) or (B)] and Ant1 form [(C) or (D)] can be isolated by the following method. ] can be separated.

すなわち、粗β−ヒドロキシエステル(V)を、アZr
L末:lA/!;f C7!;ec4.mol)に/ 
0 % H(?4aC1,20m1を加えて室温でS分
間攪押抜濾過し、水、特級エタノール、エーテルで順次
洗浄する。生成した亜鉛末を72θCで70分間活性化
後、無水ベンゼン;!rOvtlに加え、メチルコーフ
ロモ7’ aビオネートミルg、tAgり(1,2aq
、 mol)、コーチオフエンアルデヒド(1) ; 
l/l、7 s yを加え、7時間還流攪拌する。反応
終了後、10%Hαaq、で酸性後、エーテルから抽出
する。エーテル層を飽和NaHcO3aq、、飽和Na
C1aq、で順次洗い、均S04で脱水乾燥後、溶媒を
溜去して粗生成物メチ7I/3−C2−チェニル)−3
−ヒドロキシーコーメチルゾロピオネート((J’) 
+ (り + (ff) + (乙)):g、’19g
gf (定量的)を得る。これはTL=C及びNMRか
ら殆んど純粋であるので、精製することなく次の反応へ
用いた。
That is, the crude β-hydroxy ester (V) is
L end: lA/! ;f C7! ;ec4. mol) to/
Add 0% H (?4aC1, 20ml, stir and extrude filtrate at room temperature for S minutes, wash sequentially with water, special grade ethanol, and ether. After activating the generated zinc powder at 72θC for 70 minutes, anhydrous benzene;!rOvtl In addition, Methyl Cofflomo 7'a Bionate Milg, tAgli (1,2aq
, mol), coachofenaldehyde (1);
Add l/l, 7 sy and stir under reflux for 7 hours. After the reaction is completed, the mixture is acidified with 10% Hαaq and extracted from ether. The ether layer was saturated with NaHcO3aq, saturated Na
After successively washing with C1aq and dehydrating and drying with S04, the solvent was distilled off to obtain the crude product Methi7I/3-C2-chenyl)-3.
-Hydroxy-comethylzolopionate ((J')
+ (ri + (ff) + (ot)):g, '19g
gf (quantitative) is obtained. Since this was almost pure from TL=C and NMR, it was used in the next reaction without purification.

(3)十傍)+(至)+(4); IR(Cα4);   3SOOem   (OH)/
’7.10cm−1、/ 73!;cm−”(sh) 
(COOMe)NMR(A(7MHz  FT% CD
Cl2)Syn ; (3)+&’)        
       ant I 個+c乙)i233 d 
J−’Z/  sec−Me   l//b d  J
−7,/sec−Me3.1s97  s  3HCO
OMe   3.73!;  s  3HCOOMeふ
305t    μ+OHふ029 dd /H畔0H
J4.2            J口数9.27Sy
n (CJ)”(GQ) / antl (Ct)+(
ω)=//’739(COOMeによる比) 参考例ツ ((3)十例+(8)+(乙) )         
   C7)β−ヒドロキシエステルのi合物(C7)
+(ト)+(イ)+(4)):、1−fをCH2Cl2
5θ罰に溶かし、P D C;29 y ヲ加しテ室温
テs 日間i押抜、5to2 (c−100):SOf
を用いてクロマトに付し、Ac0Et  の溶出部から
油状物を得る。これを再度5t02(C−2θO);2
0ofを用いてカラムクロマトに付し、n−ヘキサン/
 Ac0Et=/q//の溶出部からβ−ケトエステル
(7);り3290f (収率g7%)を得る。
(3) + (to) + (4); IR (Cα4); 3SOOem (OH)/
'7.10cm-1, / 73! ;cm-”(sh)
(COOMe)NMR(A(7MHz FT% CD
Cl2)Syn; (3)+&')
ant I pieces + c Otsu) i233 d
J-'Z/ sec-Me l//b d J
-7,/sec-Me3.1s97s 3HCO
OMe 3.73! ; s 3HCOOMefu305t μ+OHfu029 dd /H 0H
J4.2 J number of units 9.27Sy
n (CJ)” (GQ) / antl (Ct)+(
ω) = //'739 (ratio according to COOMe) Reference example ((3) 10 cases + (8) + (Otsu))
C7) i-compound of β-hydroxyester (C7)
+ (g) + (a) + (4)):, 1-f is CH2Cl2
Dissolved in 5θ punishment, PDC; 29 y added room temperature test, day i push, 5to2 (c-100): SO of
The mixture was subjected to chromatography using Ac0Et to obtain an oily substance from the eluted portion of Ac0Et. This is repeated 5t02(C-2θO);2
Column chromatography using 0of, n-hexane/
β-ketoester (7);

(7);元累分析(Hlgh massによる)cg 
HIQO3Sとして 計算値 19g、03g 測定値 19g、03/ IR(Cα4)  7670m   (カルがニル)1 /7弘0crn(エステル) NMR(乙θMH2FT、 cocg3、TMS)/、
5″/、2  d  J−Z/   3Hsec−Me
3.706 s       3HC00Mθ442乙
2  q  J=7/   /Hメチン7A9’A d
d  J8b=左/  J8o−1/ /HHa7/l
I’l dd  Jba−&/ 、Jbo−3,7/H
Hb7.7gS dd  Jl)(=J、7  J8o
−l/ /HHc〔酵母のスクリーニング試験〕 液体培地701にスラントからかき取った酵母(KSY
−/ないしKSY−39)な少量加え、30Cで2日間
振とり培養後、基質として化合物(7)約5■を加え、
更に3日間振とり培養する。その稜、エーテルで抽出し
、エーテル溜去後、残渣をTLC(シリカゲル:n−ヘ
キサン/Ac0Et−t//)、6(7MHz FT−
NMRで検索した。
(7); Original cumulative analysis (by Hlgh mass) cg
Calculated value as HIQO3S 19g, 03g Measured value 19g, 03/ IR (Cα4) 7670m (Calganiru) 1/7 Hiro0crn (ester) NMR (OtsuθMH2FT, cocg3, TMS)/,
5″/, 2 d J-Z/ 3Hsec-Me
3.706 s 3HC00Mθ442 Otsu2 q J=7/ /H Methine7A9'A d
d J8b=Left/J8o-1//HHa7/l
I'l dd Jba-&/ , Jbo-3,7/H
Hb7.7gS dd Jl) (=J, 7 J8o
-l/ /HHc [Yeast screening test] Yeast (KSY
-/ or KSY-39) was added, and after shaking culture at 30C for 2 days, about 5μ of compound (7) was added as a substrate.
Culture by shaking for an additional 3 days. The ridge was extracted with ether, and after distilling off the ether, the residue was analyzed by TLC (silica gel: n-hexane/Ac0Et-t//), 6 (7 MHz FT-
Searched by NMR.

その結果、少なくともKSY−グ、5%乙、ワ、3%)
2.161.24’、2乙及び3乙が生成物を与えてい
ることがわかった。
As a result, at least KSY-G, 5% Otsu, Wa, 3%)
It was found that 2.161.24', 2 Otsu and 3 Otsu gave the product.

実施例/ (’7)            (4Q      
(4)2tのフラスコに基質(7))、70θ■、洗浄
菌体(KSY−=7) / 00 F、シュークロース
/θ02.82401IθOMを加え、30Cでt時間
様とう攪瞳、シュークロース/θ0tを加え、コル時間
後に洗     C9H1゜生菌体(KSY−7430
01、シュークロース   計算値 =1007な加え
合計4’5時間30Cで振とう培養   測定値 :す
る。この反応なユ回行ない、反応終了後セライ  〔α
〕、1θ8トな用いて沖過し、F液をAc0Et から
抽出する。  IR(Cα4)AcOEt層をAfti
 S 04で脱水乾燥後、溶媒を溜去す7;) ト油状
mi 2 qllll y k得ル。コレ’x StO
2NMR(<zooMF(C−コoo):soyを用い
てカラムクロマト   123g  dに付し、jl 
−ヘキサン/ Ac0E t=/9// 〜9//の 
  2.g9/ Cl−Cl溶出部から還元体佼) +
 (4) ; !; 3 g niな得る。n−3,0
7!;dヘキサン / Ac0E’t−9//の溶出部
からant l <6);    3.700  sb
!;miを得る。前者は更にローパーカラムを用い  
 !t30g  tで精製し、浴出順に5ynu);、
23乙l1v(収率/ム’7  1,9.t2 dd%
)ant+(乙)?  233mg (合計233+A
3=2qgmy   &97乙dd(収率、21/・%
)を得る。             ′7.21/l
グddローパーカラム (シリカケ9ル) 溶媒;n−ヘキサン/ Ac0E t=3//流速; 
/ Oml/ mln 〔化合物(’+) (5yn)の物理的性質〕元素分析
(Hlgh Massによる)ぅ03Sとして :OθO5l + o o、 o s 。
Example/ ('7) (4Q
(4) Add substrate (7)), 70θ■, washed bacterial cells (KSY-=7)/00F, sucrose/θ02.82401IθOM to a 2t flask, and stir at 30C for t hours. Add θ0t and wash C9H1° live bacterial cells (KSY-7430
01, Sucrose Calculated value = 1007, and cultured with shaking at 30C for a total of 4'5 hours Measured value: Yes. This reaction is repeated several times, and after the reaction is complete,
] and 1θ8 to extract liquid F from Ac0Et. Afti the IR (Cα4) AcOEt layer
After dehydration and drying with S04, the solvent is distilled off to obtain an oily mixture. Kore'x StO
2NMR (<zooMF (C-Cooo): column chromatography using 123g d, jl
-Hexane/Ac0E t=/9// ~9//
2. g9/ Reduced product from Cl-Cl elution part) +
(4); ! ; 3 g ni get. n-3,0
7! ;d from the elution part of hexane/Ac0E't-9// ant l <6); 3.700 sb
! ;get mi. The former further uses a Roper column.
! Purified with t30g t, 5ynu in order of bathing);
23 otl1v (yield/mu'7 1,9.t2 dd%
) ant+? 233mg (total 233+A
3=2qgmy &97dd (yield, 21/・%
). '7.21/l
Roper column (silica gel) Solvent: n-hexane/Ac0E t=3//Flow rate;
/Oml/mln [Physical properties of compound ('+) (5yn)] Elemental analysis (according to Hlgh Mass)々03S: OθO5l + o o, o s.

(C=ふ/、CHα3、−27.IC)3!; 20 
cm  ”  (OH)1720cm−1%/73.!
;cm  ’(sh)’  COOMeIzlFT−N
MR%CDC/3、TMSIJ=’Z’/  3Hse
c−Me J=7/  4411   /Hメチン  (J2,3
=44弘)J=lAF    /H0H 38COOMe J=taq、titt      ++oH(J、34
%)β−ヒドロキシエステルの混合物(■+el)+(
3)+<1=)):ist、q、(+)MTPA(に 
2.?A”i (12θq、rnol)にピリジンθ!
;telを加え、室温で3日間攪拌後、水を加えてエー
テルから抽出する。エーテル層を飽和Nactaq、で
洗い、4804  で脱水乾燥して溶媒を溜去すると油
状物を得る。これを5t02(C−200)? 20?
用いてカラムクロマトに付し、n−ヘキサン/ Ac0
E t−/q//の溶出部から(+) M T P A
エステルの混合物((f)+ (9) + Cl0)+
 (//) ) ;ユgθ71Ivを得る(収率g7%
)。
(C=fu/, CHα3, -27.IC) 3! ; 20
cm” (OH)1720cm-1%/73.!
;cm '(sh)' COOMeIzlFT-N
MR%CDC/3, TMSIJ='Z'/3Hse
c-Me J=7/ 4411 /H methine (J2,3
=44 Hiroshi) J=lAF /H0H 38COOMe J=taq, titt ++oH(J, 34
%) mixture of β-hydroxy esters (■+el)+(
3)+<1=)): ist, q, (+) MTPA (to
2. ? Pyridine θ in A”i (12θq,rnol)!
; Add tel and stir at room temperature for 3 days, then add water and extract from ether. The ether layer was washed with saturated Nactaq, dried over 4804 and evaporated to give an oil. Is this 5t02 (C-200)? 20?
Column chromatography using n-hexane/Ac0
From the elution part of E t-/q// (+) M T P A
Mixture of esters ((f) + (9) + Cl0) +
(//) ); Obtain Yugθ71Iv (yield g7%
).

σ) + rq> + (io)+ <ii> ;40
0MHz FT−NMR(CDC/3、TMS)Syn
 ; (&) +(q)          ant 
l ; (/(17)+(//)//り9  d  J
−’l/sec−Me  iθ73  d  J−7/
 5ec−441/323 d  J=2/  sec
−Me i03’A d J−2/ sec−M〔3,
6/り s    3HCOOMe  3.乙デ3  
S  3HC00M13J’、57/  s  3HC
OOMe  、1JO2s 3HCOOMeム!;20
 d  J−’Z/     ム39弘d J=/θ7
ムlI9’l d  J=4:、?     13!;
g d J−/θS蓼考例ダ (2)R−H佼)R−H (、g)  R−MTPA(+)   ぐF)R−MT
PA(+)I)(7)?/ll&qを無水:c −f 
k j tnl VC溶かし、アルゴン気流下、OC攪
拌下、Zn(8H4)2/乾燥エーテル溶液S−な加え
、同温度で7時間攪拌、  後、水を加え、/θ%Hα
で酸性にしてからエーテルから抽出する。エーテル層を
飽和NaHCO3aq、飽和NaαaQ、で順次洗い、
Mpso4で脱水乾燥後溶媒を溜去して油状物:/4t
Otqを得る。
σ) + rq> + (io)+ <ii>;40
0MHz FT-NMR (CDC/3, TMS) Syn
; (&) +(q) ant
l; (/(17)+(//)//ri9 d J
-'l/sec-Me iθ73 d J-7/
5ec-441/323 d J=2/sec
-Me i03'A d J-2/ sec-M [3,
6/ri s 3HCOOMe 3. Otsude 3
S 3HC00M13J', 57/s 3HC
OOMe, 1JO2s 3HCOOMe! ;20
d J-'Z/ Mu39hirod J=/θ7
MulI9'l d J=4:,? 13! ;
g d J-/θS 蓼例DA(2)R-H佼)R-H (,g) R-MTPA(+) ふ)R-MT
PA(+)I)(7)? /ll&q anhydrous:c-f
k j tnl Dissolved in VC, under argon stream, under OC stirring, added Zn(8H4)2/dry ether solution S-, stirred at same temperature for 7 hours, then added water, /θ%Hα
Acidify with water and extract from ether. The ether layer was sequentially washed with saturated NaHCO3aq and saturated NaαaQ,
After dehydration and drying with Mpso4, the solvent was distilled off to obtain an oily substance: /4t
Get Otq.

■+(Q:(+θθMHz  FT−NMRCDCts
、TMS)lコ32  d   J−7,3sec−M
e2ggOqq  、  J−1A4    ’l/ 
   /Hメチン3.2/3 1:+r、s     
 /HOH3、Ag!;   s    、?HCOO
Mec f a n t l (G)+(/;)) :
 COOMe :C3,73011)上記Syn体((
3)+(4’) ) : 27 wtl(+)MTPA
α’I / x9 (i 2 eq、mol)をピリジ
ン0..5− m7!に溶か/ し、室温でtI6時間攪拌後、水な加えてエーテルから
抽出する。エーテル層を飽和N aCtaq 。
■+(Q:(+θθMHz FT-NMRCDCts
, TMS) 32 d J-7, 3sec-M
e2ggOqq, J-1A4'l/
/H methine 3.2/3 1:+r,s
/HOH3, Ag! ;s,? H.C.O.O.O.
Mec f a n t l (G)+(/;)):
COOMe:C3,73011) The above Syn body ((
3)+(4')): 27 wtl(+)MTPA
α'I/x9 (i 2 eq, mol) was dissolved in pyridine 0. .. 5-m7! After stirring at room temperature for 6 hours, add water and extract from ether. Saturate the ether layer with NaCtaq.

で洗い、A4 S O、で脱水乾燥後、溶媒を溜去して
油状物を得る。・これをシリカグルプレートを用いて調
製TLc(、、−ヘキサン/ Ac0E t=3// 
)に付し、(+) M T P Aエステル(Syn体
) :(1)+Cq;3g、!r〜を得る(収率乙qチ
)。
After washing with water and dehydrating and drying with A4 SO, the solvent was distilled off to obtain an oil.・Prepare this using a silica glu plate TLc (,, -hexane/Ac0E t=3//
), (+) M T P A ester (Syn form): (1) + Cq; 3 g,! Obtain r~ (yield qchi).

(lr)+(q): (4’0(7MHz FT NM
R,cocg3、TMS)i/gOd  J−7,/ 
  seC−Mei32’l   d   J−A、g
    sec−Me3、so7 d J−0,9ON
θ 3、’l’l−9tj   J−C90Me3、乙/g
   s   3日  COOMe3、!r73   
s   、?HCOOMeム379  (I  J=’
2/  早+OM T P A(+)ム1Iq3 d 
J=g、3 H+OMTPA←)(s)+(9):元素
分析 (Hlgh Massによる)C19H1905
F3S  として 計算値 ダ/ムOqO 測定値 弘/ム09θ 参考例3 (イ)            C) 実施例1で得られた化合物(p) : 、t 、5−1
19、←)MTPA&:ざ3 ’12 (l!eq、m
ol )にピリジンθ3 wtlを加え、室温で737
時間攪拌後、水を加えてエーテルから抽出する。エーテ
ル層を飽和Naαaq、で洗いh1gS04で脱水乾燥
後、溶媒な溜去して油状物を得る。これをシリカゲルプ
レートを用いて調製TLC(溶媒;n−ヘキサン/Ac
0Et−3//  )に付し、(+) M T P A
エステル(9) ; g 3 wqを得る。
(lr)+(q): (4'0(7MHz FT NM
R, cocg3, TMS) i/gOd J-7,/
seC-Mei32'l d J-A,g
sec-Me3, so7 d J-0,9ON
θ 3, 'l'l-9tj J-C90Me3, Otsu/g
s 3rd COOMe3,! r73
S,? HCOOMemu379 (I J='
2/ Haya+OM T P A(+)mu1Iq3 d
J=g, 3 H+OMTPA←)(s)+(9): Elemental analysis (by Hlgh Mass) C19H1905
Calculated value as F3S Da/muOqO Measured value Hiro/mu09θ Reference example 3 (a) C) Compound (p) obtained in Example 1: , t , 5-1
19, ←) MTPA&:za3 '12 (l!eq, m
Add pyridine θ3 wtl to 737
After stirring for an hour, add water and extract from ether. The ether layer was washed with saturated Naαaq, dehydrated and dried over h1gS04, and the solvent was distilled off to obtain an oil. This was prepared using a silica gel plate for TLC (solvent: n-hexane/Ac
0Et-3// ), (+) M T P A
Ester (9); g 3 wq is obtained.

(9):’+00MH2FT  NMR,(CDCj3
、TMS)1323  d  J−’7./   se
c−Me3.1./II  s  3HCOOMe C
?’l/9 )ム320  d  J干′7./ cf (//) ; 1179  d  J−ムざ 光学純度: ?+/q+7A/ 参考例6 0MTPべ+)3) 。H2N、OMTPK+)(q)
                C/2)(9) :
 73 mIIをCH2(J2  乙−に溶かし、ドラ
イブイス−アセトン冷却下オゾンを30分間吹き込む。
(9):'+00MH2FT NMR, (CDCj3
, TMS) 1323 d J-'7. / se
c-Me3.1. /II s 3HCOOMe C
? 'l/9)mu320dJd'7. / cf (//); 1179 d J-Muza optical purity: ? +/q+7A/ Reference example 6 0MTPbe+)3). H2N, OMTPK+) (q)
C/2) (9):
73 mII was dissolved in CH2 (J2 Otsu-), and ozone was blown into the solution for 30 minutes while cooling in a dry bath with acetone.

その後、室温に戻して30 % H2O2aq、 2 
mlを加え、20分間攪拌後、水を加えてエーテルから
抽出する。エーテル層な飽和Naαaq、で洗い、Mg
SO4で脱水乾燥後溶媒を溜去して油状物な得る。これ
なCH2N2/エーテル溶液で処理してメチル死後溶媒
を溜去し、油状物を得る。これをシリカゲルプレートを
用いて調製TLC(溶媒;n−ヘキサン/ Ac0Et
−J//)に付し、ジメチルエステル(l刀;9IIv
な得る。
After that, return to room temperature and add 30% H2O2aq, 2
ml and after stirring for 20 minutes, water is added and extracted from ether. Wash with ethereal saturated Naαaq, Mg
After dehydration and drying with SO4, the solvent was distilled off to obtain an oily substance. After treatment with a CH2N2/ether solution, the methyl post-mortem solvent is distilled off to give an oil. This was prepared using a silica gel plate for TLC (solvent: n-hexane/Ac0Et
-J//) and dimethyl ester (9IIv
I can get it.

(/、2) ?弘θ(7MHz  FT  NMR(C
DC(3、TMS)cf antlpocle 12/!;  d  J−7,3sec−Me 117
3 d J=73 sec−Me左793  d  J
−、?、+  リ÷OMTPべ+)参考例7 0H6MTPK+) (乙)(//) 実施例/で得られた化合物(A) : s II vq
 、 (+)MrpAa;g 3 rxl (12eq
、mol)にビリジ:/ 0.3 rttlを加え、室
温で/3′7時間攪拌後、水な加えてエーテルから抽出
する。エーテル層を飽和Nactaq、で洗い、A!4
So4で脱水乾燥後、溶媒を溜去して油状物を得る。こ
れをシリカゲルプレートな用いて調製TLC(溶媒;n
−ヘキサン/ Ac0At −3// )に付し、(+
) M T P A /エステル(//) /θユ5〜
を得る。
(/, 2)? Hiro θ (7MHz FT NMR (C
DC (3, TMS) cf antlpocle 12/! ; d J-7, 3sec-Me 117
3 d J=73 sec-Me left 793 d J
-,? ,+Re÷OMTPbe+) Reference Example 7 0H6MTPK+) (B)(//) Compound (A) obtained in Example/: s II vq
, (+)MrpAa;g 3 rxl (12eq
, mol) was added with 0.3 rttl of viridi, and after stirring at room temperature for 7 hours, water was added and extracted from ether. Wash the ether layer with saturated Nactaq, A! 4
After dehydration and drying with So4, the solvent is distilled off to obtain an oil. This was prepared using a silica gel plate for TLC (solvent; n
-hexane/ Ac0At -3// ), (+
) M T P A /ester (//) /θyu5~
get.

(//) ;4’00MHz FT NMR(CDcg
3、TMS)i073  d  J−’13   se
c−Me     cf (/θ〕;参考例g C1/)              C/3)C//
):92!;qをCH2(j2  b Ml;に溶かし
、ドライアイス−アセトン冷却下、オゾンを30分間吹
き込む。その後室温に戻して30%H2O2aQ−5r
xlな加え、20分間攪拌後、水を加えてエーテルから
抽出する。エーテル層を飽和Naαaq、で洗い、Mg
SO4で脱水乾燥後、溶媒を溜去して油状物を得る。こ
れをCH2N2/エーテル溶液で処理してメチ層化後、
溶媒を溜去すると油状物を得る。これをシリカダルプレ
ートを用いて調製TLC(溶媒;jl −ヘキサy’ 
/ Ac0E t−3//ン に付し、ジメチルエステ
ルC/3) ; 3.3 WIgを得る。
(//) ;4'00MHz FT NMR (CDcg
3, TMS) i073 d J-'13 se
c-Me cf (/θ]; Reference example g C1/) C/3) C//
):92! Dissolve q in CH2 (j2 b Ml; and blow in ozone for 30 minutes while cooling with dry ice-acetone. Then return to room temperature and add 30% H2O2aQ-5r.
After stirring for 20 minutes, water is added and extracted from ether. The ether layer was washed with saturated Naαaq, Mg
After dehydration and drying with SO4, the solvent is distilled off to obtain an oil. After treating this with CH2N2/ether solution to form a methyl layer,
Distillation of the solvent yields an oil. This was prepared by TLC using a silica dull plate (solvent; jl-hexay'
/Ac0Et-3//n to give dimethyl ester C/3); 3.3 WIg.

(/3);弘(70MHz  FT−NMR(CDα3
、TMS)cf (AntlpOdθ) 0.67  d  J−1sec−Me  II’72
 d  J−2/ sec−Me実施例a〜g Mw4/6(C1gH19SO5F31(1)    
(10) 一次スクリーニングで良好な結果を得たKSY−グ、S
17、ざ、/6.2乙、36について検討した。液体培
地ioomiにスラントからかき取った酵母を少量加え
、3θCで3日間振とう培養後、基質(7)約3Oyn
gを加え、更に3日間振とう培養する。次にセライトを
用いて各々の反応物を濾過し、ろ液をエーテルから抽出
する。エーテル層を4SO4で脱水乾燥後、溶媒な溜去
するとそれぞれ油状物を得る。
(/3); Hiro (70MHz FT-NMR (CDα3
, TMS) cf (AntlpOdθ) 0.67 d J-1sec-Me II'72
d J-2/ sec-Me Examples a to g Mw4/6 (C1gH19SO5F31 (1)
(10) KSY-G, S, who obtained good results in the primary screening
17, Za, /6.2 Otsu, 36 was considered. A small amount of yeast scraped from the slant was added to the liquid medium ioomi, and after shaking culture at 3θC for 3 days, about 3 Oyn of substrate (7) was added.
g and cultured with shaking for an additional 3 days. Each reaction is then filtered through Celite and the filtrate is extracted from ether. After dehydrating and drying the ether layer with 4SO4, the solvent was distilled off to obtain each oil.

各々の粗抽出物に(+)MTPAO7A W (12e
cImol )を加え、更にピリジンθ5罰を加えて室
温で73時間攪拌後、水を加えてエーテルから抽出する
。エーテル層な飽和Naclaq、で洗い、 A4js
’o 4で脱水乾燥後、溶媒を溜去して油状物な得る。
(+) MTPAO7A W (12e
After adding pyridine θ5 and stirring at room temperature for 73 hours, water was added and extracted from ether. Wash with ethereal saturated Naclaq, A4js
After dehydration and drying at 4 o'clock, the solvent was distilled off to obtain an oily product.

これをシリカダルプレートを用いて調製TLC(溶媒二
n−ヘキサン/ Ac0Et −3// )に付し、(
+) M T P Aエステルな得る。
This was subjected to preparative TLC (solvent di-n-hexane/Ac0Et-3//) using a silica dull plate, and (
+) MTP A ester obtained.

結果を次式及び第2表に示す。The results are shown in the following formula and Table 2.

6FA− も 老 饗  ) ) 苓 釣 褐 さ Q詠 第1頁の続き 0発 明 者 越地弘子 和光市広沢2番1号理化学研究 所内 0発 明 者 古市昭也 川崎市多摩区西生田4−18−7 4016FA- too Old banquet)) Rei fishing brown sa Q song Continuation of page 1 0 shots clear person Hiroko Koshichi 2-1 Hirosawa, Wako City Physical and Chemistry Research Inside the office 0 shots Akiya Furuichi 4-18-7 Nishiota, Tama-ku, Kawasaki City 401

Claims (1)

【特許請求の範囲】 (1)一般式: (ただし、式中、Xは、α−C)(3またはβ−CH3
、Yはα−OHまたはβ−OHを示す。) で表わされるβ−ヒドロキシエステル。 @ Xがα−CH3、Yがα−OHである特許請求の範
囲第1項記載の化合物。 G3)  Xがα−CH3、Yがβ−OHである特許請
求の範囲第1項記載の化合物。 に) Xがβ−CH3、Yがα−OHである特許請求の
範囲第1項記載の化合物。 (至) xがβ−CH3、Yがβ−OHである特許請求
の範囲第1項記載の化合物。 (6)一般式: (式中、Rはアルキル基を示す。) で表わされる化合物を、カンデイダ(CandLda)
属、エンドマイコシシス(Endomycopsls)
属、ハンセヌラ(Hansθnula )属、クロッケ
ラ(Kloeckera )属、リポマイセス(Llp
omyces)属、サツカロマイセス(sacchar
omyces )属、シゾサツカCI”fイセス(Sc
hlzosaccharomyces)属、スポロボロ
マイセス(Sporobolomyces )属に属す
る微生物群から選ばれた微生物又はその菌体に接触せし
めて、一般式: (ただし、式中、Rは前記に同じ。) で表わされる化合物を得ることを特徴とするβ−ヒドロ
キシエステルの製造法。
[Claims] (1) General formula: (wherein, X is α-C) (3 or β-CH3
, Y represents α-OH or β-OH. ) β-hydroxy ester represented by: @ The compound according to claim 1, wherein X is α-CH3 and Y is α-OH. G3) The compound according to claim 1, wherein X is α-CH3 and Y is β-OH. 2) The compound according to claim 1, wherein X is β-CH3 and Y is α-OH. (To) The compound according to claim 1, wherein x is β-CH3 and Y is β-OH. (6) General formula: (In the formula, R represents an alkyl group.) A compound represented by Candida (CandLda)
Genus, Endomycopsls
Genus Hansenula, Genus Kloeckera, Genus Lipomyces (Llp
saccharomyces), saccharomyces
omyces), genus Schizosatsuka CI”f Ises (Sc
A compound represented by the general formula: (wherein R is the same as above) is contacted with a microorganism selected from the microorganism group belonging to the genus hlzosaccharomyces and genus Sporobolomyces, or its bacterial cells. A method for producing a β-hydroxy ester, characterized in that it obtains a β-hydroxy ester.
JP3808483A 1983-03-08 1983-03-08 Novel beta-hydroxy ester and its preparation Pending JPS59163382A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP3808483A JPS59163382A (en) 1983-03-08 1983-03-08 Novel beta-hydroxy ester and its preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3808483A JPS59163382A (en) 1983-03-08 1983-03-08 Novel beta-hydroxy ester and its preparation

Publications (1)

Publication Number Publication Date
JPS59163382A true JPS59163382A (en) 1984-09-14

Family

ID=12515603

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3808483A Pending JPS59163382A (en) 1983-03-08 1983-03-08 Novel beta-hydroxy ester and its preparation

Country Status (1)

Country Link
JP (1) JPS59163382A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003078418A1 (en) * 2002-03-19 2003-09-25 Mitsubishi Chemical Corporation 3-hydroxy-3-(2-thienyl)propionamide compound, process for producing the same, and process for producing 3-amino-1-(2-thienyl)-1-propanol compound therefrom
DE10237272A1 (en) * 2002-08-14 2004-03-11 Consortium für elektrochemische Industrie GmbH Preparation of optically pure (3RS)-2-oxy-3-(2-thienyl)-propylamine compound, useful as drug intermediate for e.g. serotonin and norepinephrine uptake inhibitor duloxetine, by enantioselective Reformatsky type synthesis via new intermediate
US7659409B2 (en) 2002-03-19 2010-02-09 Mitsubishi Chemical Corporation 3-Hydroxy-3-(2-thienyl) propionamides and production method thereof, and production method of 3-amino-1-(2-thienyl)-1-propanols using the same

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003078418A1 (en) * 2002-03-19 2003-09-25 Mitsubishi Chemical Corporation 3-hydroxy-3-(2-thienyl)propionamide compound, process for producing the same, and process for producing 3-amino-1-(2-thienyl)-1-propanol compound therefrom
US7659409B2 (en) 2002-03-19 2010-02-09 Mitsubishi Chemical Corporation 3-Hydroxy-3-(2-thienyl) propionamides and production method thereof, and production method of 3-amino-1-(2-thienyl)-1-propanols using the same
DE10237272A1 (en) * 2002-08-14 2004-03-11 Consortium für elektrochemische Industrie GmbH Preparation of optically pure (3RS)-2-oxy-3-(2-thienyl)-propylamine compound, useful as drug intermediate for e.g. serotonin and norepinephrine uptake inhibitor duloxetine, by enantioselective Reformatsky type synthesis via new intermediate

Similar Documents

Publication Publication Date Title
Kawagishi et al. Erinacines J and K from the mycelia of Hericium erinaceum
Chang et al. Simultaneous production of three phenazine pigments by Pseudomonas aeruginosa Mac 436
Cutler et al. Koninginin B: a biologically active congener of koninginin A from Trichoderma koningii
EP0204009B1 (en) Process for producing diol and furan and microorganism capable of same
Nakamura et al. New total syntheses of (+)-macrosphelides C, F and G
AU641286B2 (en) Process for the preparation of carebastine
DE2558190C2 (en)
JPS59163382A (en) Novel beta-hydroxy ester and its preparation
JP3878204B2 (en) Oxidation of glycoside-substituted paclitaxels leading to paclitaxel and paclitaxel precursors and novel taxane compounds formed as intermediates
Frye et al. Synthesis of potential mechanism-based inactivators of lanosterol 14. alpha.-methyl demethylase
Wheatley et al. Ketals of L-rhamnoheptonolactones: Potential mimics of L-rhamnose
Asakawa et al. Sesquiterpene lactones of Eremanthus incanus and Porella japonica. Crystal structure and stereochemistry of eregoyazidin
EP0019148B1 (en) Antibiotic suppressing the growth of microorganisms and its manufacture by fermentation
EP0187049B1 (en) Micromonospora microorganisms and macrolide antibiotic production therewith
GB2152028A (en) Antitumor antibiotic
US3873529A (en) Novel antibiotic ascofuranone and process for the production thereof
JPH04228092A (en) Production of optically active secondary alcohol compound
Olejniczak et al. Lactones 7: 1. Enantioselective lactonization of racemic ethyl (5, 5-dimethyl-2, 3-epoxycyclohex-1-yl) acetate
US6177457B1 (en) Process for the preparation of indacene compound
Perkins et al. Stereoselective synthesis of a novel spiroacetal-dihydropyrone related to auripyrone
JPS58193696A (en) Production of anthracyclines
US5292898A (en) Process for the stereoselective preparation of 5-substituted delta-lactones and use thereof
US4456558A (en) Polyprenyl ketone derivatives
JPS61289899A (en) Production of optically active 2-halo-1-phenyl-ethanol and ester thereof
JPH0261934B2 (en)